Search research articles
Contact Us
Filters
Showing results (61-70 of 128) with videos related to
Page
of 13
Sort By:
American Journal of Hematology
|
October 26, 2005
Guidance on the use of miglustat for treating patients with type 1 Gaucher disease
Neal J Weinreb, John A Barranger, Joel Charrow, et al.
Human Molecular Genetics
|
August 3, 2019
Intravenous infusion of iPSC-derived neural precursor cells increases acid β-glucosidase function in the brain and lessens the neuronopathic phenotype in a mouse model of Gaucher disease
Yanyan Peng, Benjamin Liou, Venette Inskeep, et al.
Human Molecular Genetics
|
March 14, 2007
Combined saposin C and D deficiencies in mice lead to a neuronopathic phenotype, glucosylceramide and alpha-hydroxy ceramide accumulation, and altered prosaposin trafficking
Ying Sun, David P Witte, Matt Zamzow, et al.
Blood
|
March 11, 2004
Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy
Richard J Wenstrup, Laurie Bailey, Gregory A Grabowski, et al.
The Journal of Cell Biology
|
May 26, 2010
The role of UDP-Glc:glycoprotein glucosyltransferase 1 in the maturation of an obligate substrate prosaposin
Bradley R Pearse, Taku Tamura, Johan C Sunryd, et al.
American Journal of Hematology
|
February 4, 2014
Position statement: National Gaucher Foundation Medical Advisory Board, January 7, 2014
John A Barranger, Roscoe O Brady, Gregory A Grabowski, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 17, 2003
Lysosomal enzymes are released from cultured human macrophages, hydrolyze LDL in vitro, and are present extracellularly in human atherosclerotic lesions
Jukka K Hakala, Riina Oksjoki, Petri Laine, et al.
Journal of Lipid Research
|
August 28, 2007
Apolipoprotein E-deficient lipoproteins induce foam cell formation by downregulation of lysosomal hydrolases in macrophages
DongFang Wu, Chakradhari Sharan, Hong Yang, et al.
The Journal of Pediatrics
|
January 24, 2007
Gaucher disease: progressive mesenteric and mediastinal lymphadenopathy despite enzyme therapy
T Andrew Burrow, Mitchell B Cohen, Ronald Bokulic, et al.
Molecular Genetics and Metabolism
|
October 2, 2013
Gaucher disease: chemotactic factors and immunological cell invasion in a mouse model
Manoj Kumar Pandey, Nicholas A Jabre, You-Hai Xu, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 128) with videos related to
Sort By:
Page
of 13
American Journal of Hematology
|
October 26, 2005
Guidance on the use of miglustat for treating patients with type 1 Gaucher disease
Neal J Weinreb, John A Barranger, Joel Charrow, et al.
Human Molecular Genetics
|
August 3, 2019
Intravenous infusion of iPSC-derived neural precursor cells increases acid β-glucosidase function in the brain and lessens the neuronopathic phenotype in a mouse model of Gaucher disease
Yanyan Peng, Benjamin Liou, Venette Inskeep, et al.
Human Molecular Genetics
|
March 14, 2007
Combined saposin C and D deficiencies in mice lead to a neuronopathic phenotype, glucosylceramide and alpha-hydroxy ceramide accumulation, and altered prosaposin trafficking
Ying Sun, David P Witte, Matt Zamzow, et al.
Blood
|
March 11, 2004
Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy
Richard J Wenstrup, Laurie Bailey, Gregory A Grabowski, et al.
The Journal of Cell Biology
|
May 26, 2010
The role of UDP-Glc:glycoprotein glucosyltransferase 1 in the maturation of an obligate substrate prosaposin
Bradley R Pearse, Taku Tamura, Johan C Sunryd, et al.
American Journal of Hematology
|
February 4, 2014
Position statement: National Gaucher Foundation Medical Advisory Board, January 7, 2014
John A Barranger, Roscoe O Brady, Gregory A Grabowski, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 17, 2003
Lysosomal enzymes are released from cultured human macrophages, hydrolyze LDL in vitro, and are present extracellularly in human atherosclerotic lesions
Jukka K Hakala, Riina Oksjoki, Petri Laine, et al.
Journal of Lipid Research
|
August 28, 2007
Apolipoprotein E-deficient lipoproteins induce foam cell formation by downregulation of lysosomal hydrolases in macrophages
DongFang Wu, Chakradhari Sharan, Hong Yang, et al.
The Journal of Pediatrics
|
January 24, 2007
Gaucher disease: progressive mesenteric and mediastinal lymphadenopathy despite enzyme therapy
T Andrew Burrow, Mitchell B Cohen, Ronald Bokulic, et al.
Molecular Genetics and Metabolism
|
October 2, 2013
Gaucher disease: chemotactic factors and immunological cell invasion in a mouse model
Manoj Kumar Pandey, Nicholas A Jabre, You-Hai Xu, et al.
Page
of 13